France at a glance
- Population
- 68.7 million 2025
- Life expectancy at birth
- 83.0 years, 2024
- People aged 65 and over
- 22.5 % of people, 2025
- Health spending per person
- 5,327 US$ per person, 2024
- Doctors
- 3.28 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
France Sedation Drugs Market Industry Trends and Forecast to 2034: Segmented by (Drug, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$39.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $95.4 Mn | — | — |
| 2025 (base) | $99.0 Mn | +$3.6 Mn | — |
| 2026 (forecast) | $102.8 Mn | +$3.8 Mn | +3.8% |
| 2027 (forecast) | $106.7 Mn | +$3.9 Mn | +7.7% |
| 2028 (forecast) | $110.7 Mn | +$4.1 Mn | +11.8% |
| 2029 (forecast) | $114.9 Mn | +$4.2 Mn | +16.1% |
| 2030 (forecast) | $119.3 Mn | +$4.4 Mn | +20.5% |
| 2031 (forecast) | $123.8 Mn | +$4.5 Mn | +25.1% |
| 2032 (forecast) | $128.6 Mn | +$4.7 Mn | +29.8% |
| 2033 (forecast) | $133.4 Mn | +$4.9 Mn | +34.8% |
| 2034 (forecast) | $138.5 Mn | +$5.1 Mn | +39.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $99.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $138.5 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 3.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Also called | Sedative-Hypnotic Drugs |
| Segments | Drug, setting and end user (see all) |
| Key players | Fresenius Kabi AG, Pfizer Inc., Hikma Pharmaceuticals PLC, Acacia Pharma (Eagle), Baxter International (see all) |
| Regulator in France | ANSMSource: ANSM, French medicines agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Sedation drugs calm patients during procedures and in intensive care, such as propofol, dexmedetomidine and midazolam.
Key segments of the sedation Drugs market include drug (Propofol, Dexmedetomidine and Midazolam) and setting (ICU, Procedural Sedation and Surgery).
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the sedation Drugs market.
Ready-to-use formulations, biosimilars and supply security programmes give the sedation Drugs market room to grow.
Drug shortages, price controls, generic competition and strict hospital budgets hold back the sedation Drugs market.
The sedation Drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by ANSM, the French medicines agency.[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.[2]
[1] ANSM, French medicines agency. Checked 14 Nov 2026.
[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for sedation Drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in France.
What doctors and scientists are doing in Sedation Drugs right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
From our blog
France · 1 shared keyword
France · 1 shared keyword
France · 1 shared keyword
France
France
France
Digital Health · France
Digital Health · France
Medical Devices · France
Medical Devices · France
Medical Devices · France
Healthcare Services · France